Diazepam

Formulation

The table below describes the formulation of diazepam and the controls morphine sulfate and gabapentin for the following in vivo experiments.

Experiment(s) Compound Dose(s) mg/kg Correction factor Dose volume mL/kg Route Vehicle Suspension / Solution
Pharmacokinetics Diazepam 3, 10 1.00 1 PO TPS Suspension
Irwin, Rotarod Diazepam 1, 3, 10, 30 1.00 5 PO TPS Suspension
Plantar incision, Diazepam 1, 3, 10 1.00 5 PO TPS Suspension
L5/L6 SNL
Plantar incision Morphine 6 1.33 1 SC Saline Solution
L5/L6 SNL Gabapentin 60 1.00 1 PO Saline Solution

L5/L6 SNL = L5/L6 spinal nerve ligation; PO = per os; SC = subcutaneous; TPS = 5% Tween 80, 5% polyethylene glycol (PEG) 300, and 90% saline


Results

Expand and Collapse accordion content

Method: Protein Binding
A table shows the results of rapid equilibrium dialysis to assess protein binding and percent recovery of diazepam. In rat plasma, diazepam was 86.6% bound to protein and 13.4% unbound and had a recovery of 93.1%. In rat brain homogenate, diazepam was 62.6% bound to protein and 37.4% unbound and had a recovery of 126.6%. Acebutolol, quinidine, and warfarin were included in the study as controls and returned values consistent with literature values.

Method: Rat Rotarod Animals were balanced across treatment groups based on body weight. Animals that achieved a latency of 40 seconds during the baseline trial were included in the study. Experimenters assessing behavior were masked to treatment. Group size was determined using power analysis.
Two graphs show the latency for male or female rats to fall off a rotarod apparatus. Responses are shown at the following time points: baseline (before treatment) and at 1, 2, 4, and 6 hours after treatment with vehicle (5% Tween 80 and 5% PEG 300 in saline, delivered PO) or diazepam (1, 3, 10, or 30 mg/kg, delivered PO). There were 10 rats per group. A significant interaction of time x treatment was found in a two-way repeated measures ANOVA for each sex. Bonferroni’s tests found a significant decrease in latency to fall relative to the vehicle group in males at 1 hour post-treatment with 30 mg/kg diazepam (p<0.01). Bonferroni’s tests found significant decreases in latency to fall relative to the vehicle group in females at 1 hour post-treatment with 10 mg/kg diazepam (p<0.05) and 30 mg/kg diazepam (p<0.0001) and at 2 hours post-treatment with 30 mg/kg diazepam (p<0.05).


This work was conducted by PsychoGenics Inc. (Paramus, NJ) in collaboration with PSPP, NINDS, NIH under contract # 75N95019D00026. Prescribing information for clinically used controls can be found at labels.fda.gov. Information for icons representing experimental design details can be found through the NINDS Office of Research Quality https://go.nih.gov/Yw2tHGI.